Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
17,173,123
-
Share change
-
-13,444
-
Total reported value
-
$244,377,218
-
Put/Call ratio
-
165%
-
Price per share
-
$14.23
-
Number of holders
-
72
-
Value change
-
+$5,182,148
-
Number of buys
-
33
-
Number of sells
-
33
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2018
As of 31 Mar 2018,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,173,123 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, MPM ASSET MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, ORBIMED ADVISORS LLC, JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.